Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC.CRL · Entity 3398 | President & COO | July 24, 2018 | July 25, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Report date July 24, 2018 · Filed July 25, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,155 |
Ending reported balance
After 2018-07-24 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2018-07-24 · Exercise / conversion · Acquired 5,474 · Balance 27,553 Row 2 · 2018-07-24 · Exercise / conversion · Acquired 8,375 · Balance 35,928 Row 3 · 2018-07-24 · Sale · Disposed 18,773 · Balance 17,155 F1: This sale occurred pursuant to a 10b5-1 Trading Plan. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $59.41 · Expires 2021-02-28 | Direct | 0 |
Reported balance
After 2018-07-24 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-07-24 · Exercise / conversion · Disposed 5,474 · Balance 0 |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.70 · Expires 2021-02-26 | Direct | 16,749 |
Reported balance
After 2018-07-24 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-07-24 · Exercise / conversion · Disposed 8,375 · Balance 16,749 |
| Common StockSEC Table I · non-derivative | IndirectBy Revocable Trust | 40,748 |
Reported balance
Holding disclosure · report date 2018-07-24 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 40,748 |
Filing footnotes · ownership attribution and instrument terms
F1: This sale occurred pursuant to a 10b5-1 Trading Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 197 | $92.90 | $18,301.30 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 24 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,956 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 402 | $92.90 | $37,343.79 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 23 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,153 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,103 | $92.89 | $102,457.67 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 22 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,555 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 121 | $92.89 | $11,239.09 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 21 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,658 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 500 | $92.88 | $46,440.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 20 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,779 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $92.87 | $27,861.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 19 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,279 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 193 | $92.86 | $17,921.98 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 18 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,579 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $92.86 | $27,856.50 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 17 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,772 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 290 | $92.85 | $26,926.50 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 16 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,072 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,000 | $92.84 | $92,840.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 15 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,362 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $92.83 | $18,566.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 14 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,362 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 889 | $92.82 | $82,516.98 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 13 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,562 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 205 | $92.81 | $19,026.05 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 12 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,451 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 166 | $92.81 | $15,405.63 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 11 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,656 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 1,669 | $92.80 | $154,883.20 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 10 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,822 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 400 | $92.80 | $37,118.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 9 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,491 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $92.79 | $9,279.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 8 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,891 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 134 | $92.79 | $12,433.19 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 7 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,991 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 712 | $92.78 | $66,059.36 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 6 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,125 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 188 | $92.77 | $17,440.76 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 5 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,837 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 300 | $92.75 | $27,825.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 4 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,025 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $92.74 | $18,548.00 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 3 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,325 Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 5,474 | $59.41 | $325,210.34 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 26, 2017 Filed May 31, 2017 10:57 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 5,502 | $40.40 | $222,280.80 |
DisclosureSEC source: 0001127602-17-019798 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,525 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2017 Filed Mar 17, 2017 11:11 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 11,717 | $90.00 | $1,054,530.00 |
DisclosureSEC source: 0001127602-17-012040 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,549 F1 · kind: This sale occurred pursuant to a 10b5-1 Trading Plan. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 11:11 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionStock Options (Right to Buy) · Derivative | 5,502 | $0.00 Strike: $40.40 | $0.00 |
DisclosureSEC source: 0001127602-17-012040 · form4.xml · derivative · entry 4 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,502 Underlying: Common Stock · 5,502 shares Expires 2020-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 15, 2017 Filed Mar 17, 2017 11:11 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Exercise / conversionCommon Stock | 5,502 | $40.40 | $222,280.80 |
DisclosureSEC source: 0001127602-17-012040 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,266 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $89.73 | $8,972.76 |
DisclosureSEC source: 0001127602-17-011428 · form4.xml · nonDerivative · entry 7 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 47,017 F1 · balance_after: On 2/17/2017: 16,524 shares were transferred from Direct Holdings to the Revocable Trust. On 3/06/2017: 3,191 shares were transferred from Direct Holdings to the Revocable Trust. Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 225 | $89.72 | $20,186.55 |
DisclosureSEC source: 0001127602-17-011428 · form4.xml · nonDerivative · entry 6 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 47,117 Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 200 | $89.72 | $17,943.20 |
DisclosureSEC source: 0001127602-17-011428 · form4.xml · nonDerivative · entry 5 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 47,342 Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $89.71 | $8,971.10 |
DisclosureSEC source: 0001127602-17-011428 · form4.xml · nonDerivative · entry 4 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 47,542 Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $89.71 | $8,971.00 |
DisclosureSEC source: 0001127602-17-011428 · form4.xml · nonDerivative · entry 3 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 47,642 Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 2,366 | $89.70 | $212,239.66 |
DisclosureSEC source: 0001127602-17-011428 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 47,742 Read SEC document |
| March 10, 2017 Filed Mar 13, 2017 19:30 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | SaleCommon Stock | 100 | $89.70 | $8,970.00 |
DisclosureSEC source: 0001127602-17-011428 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Indirect · By Revocable Trust Disclosed balance after: 50,108 Read SEC document |
| February 28, 2017 Filed Mar 1, 2017 20:16 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 654 | $89.54 | $58,559.16 |
DisclosureSEC source: 0001127602-17-009177 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,479 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 20:16 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 658 | $88.05 | $57,936.90 |
DisclosureSEC source: 0001127602-17-009177 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,133 Read SEC document |
| February 26, 2017 Filed Feb 28, 2017 13:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 803 | $88.05 | $70,704.15 |
DisclosureSEC source: 0001127602-17-008825 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,791 Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 13:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantStock Options (Right to Buy) · Derivative | 34,922 | $0.00 Strike: $88.05 | $0.00 |
DisclosureSEC source: 0001127602-17-008825 · form4.xml · derivative · entry 4 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,922 Underlying: Common Stock · 34,922 shares Expires 2022-02-24 F2 · derivative.exercise_date: Stock options vest as follows: 8,730 options vest one (1) year from the date of grant, 8,731 options vest two (2) years from the date of grant, 8,730 options vest three (3) years from the date of grant, and 8,731 options vest four (4) years from the date of grant. Read SEC document |
| February 24, 2017 Filed Feb 28, 2017 13:39 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 7,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008825 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,594 F1 · security: Consists of 7,246 unvested restricted stock units that vest as follows: 1,811 shares vest one (1) year from the date of issuance, 1,812 shares vest two (2) years from the date of issuance, 1,811 shares vest three (3) years from the date of issuance, and 1,812 shares vest four (4) years from the date of issuance. Read SEC document |
| February 22, 2017 Filed Feb 23, 2017 14:02 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 725 | $88.40 | $64,090.00 |
DisclosureSEC source: 0001127602-17-007920 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,348 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 13:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | Tax withholdingCommon Stock | 11,226 | $78.38 | $879,893.88 |
DisclosureSEC source: 0001127602-17-003431 · form4.xml · nonDerivative · entry 2 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,073 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 13:21 UTC | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL · Entity 3398 | GrantCommon Stock | 27,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-003431 · form4.xml · nonDerivative · entry 1 Molho Davide · CIK 0001507332 · Corporate Executive VP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,299 F1 · kind: Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 28, 2014. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.